Entrada Therapeutics, Inc. Insider Transactions
Entrada Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 22,935 @ $20.77 | $476.36 K | 4,402,849 | 12/10/2024 | 12/12/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 11,703 @ $20.15 | $235.79 K | 144,997 | 12/03/2024 | 12/03/2024 | |
| Sell | 5,000 @ $20.00 | $99.98 K | 73,849 | 12/02/2024 | 12/03/2024 | ||
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 4,088 @ $20.26 | $82.83 K | 156,700 | 12/02/2024 | 12/03/2024 | |
| Sell | 1,000 @ $19.97 | $19.97 K | 73,849 | 11/29/2024 | 12/03/2024 | ||
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 100 @ $20.00 | $2.00 K | 160,788 | 11/29/2024 | 12/03/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 2,700 @ $20.04 | $54.11 K | 160,888 | 11/13/2024 | 11/13/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 1,409 @ $20.01 | $28.19 K | 163,588 | 11/11/2024 | 11/13/2024 | |
| Sell | 8,637 @ $19.98 | $172.56 K | 73,849 | 11/11/2024 | 11/13/2024 | ||
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 9,554 @ $18.71 | $178.75 K | 167,742 | 11/06/2024 | 11/06/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 2,745 @ $19.32 | $53.02 K | 164,997 | 11/06/2024 | 11/06/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 5,171 @ $18.18 | $94.01 K | 177,296 | 11/05/2024 | 11/06/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 749 @ $18.02 | $13.50 K | 182,467 | 11/04/2024 | 11/06/2024 | |
|
Sethuraman Natarajan
President, Research & Develop. |
Sell | 600 @ $18.00 | $10.80 K | 183,216 | 10/16/2024 | 10/18/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 847 @ $16.00 | $13.55 K | 125,149 | 09/26/2024 | 09/30/2024 | |
| Sell | 3,195 @ $14.97 | $47.83 K | 76,486 | 09/09/2024 | 09/10/2024 | ||
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 2,642 @ $15.09 | $39.86 K | 183,816 | 09/09/2024 | 09/10/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 1,904 @ $15.07 | $28.69 K | 125,996 | 09/09/2024 | 09/10/2024 | |
|
Sethuraman Natarajan
Chief Scientific Officer |
Sell | 600 @ $15.24 | $9.14 K | 186,458 | 09/06/2024 | 09/10/2024 | |
|
Dowden Nathan J
President & COO |
Sell | 399 @ $15.19 | $6.06 K | 127,900 | 09/06/2024 | 09/10/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Entrada Therapeutics, Inc. FAQ's
The list of insiders at Entrada Therapeutics, Inc. includes MPM BIOVENTURES 2018, L.P., MPM BioVentures 2014, L.P., WENTWORTH KORY JAMES, PARMAR KUSH, 5AM Ventures V, L.P..
Insiders have sold a total of 395.23 K Entrada Therapeutics, Inc. shares in the last 12 months for a total of 3.99 M sold.
The following insiders have sold Entrada Therapeutics, Inc. shares in the last 12 months: MPM BIOVENTURES 2018, L.P. ($917.11 K), MPM BioVentures 2014, L.P. ($917.11 K), WENTWORTH KORY JAMES ($19.04 K), PARMAR KUSH ($1.07 M), 5AM Ventures V, L.P. ($1.07 M),